Blocking PARP inhibitors compromises cancer cell survival
A study from NYU Langone Health found that blocking DNA repair at sites of replication fork instability increases PARP inhibitor cytotoxicity. The mechanism relies on accumulating damage at genomic regions where DNA copying is difficult.
- Field
- cancer research
- What they did
- Researchers identified specific chromosome regions where DNA copying frequently fails and demonstrated that blocking the protective response in these areas allows damage to accumulate.
- Why it matters
- This knowledge explains why certain cancer cells are sensitive to PARP inhibitors, which exploit this vulnerability to kill the tumor.
#parp inhibitors#dna replication#cancer#nyu langone#esc02



